"Today's approval of FC2 ¿ a lower-cost, second-generation female condom ¿ is an important development in efforts to deliver affordable access to woman-initiated HIV prevention in the United States and around the world," said Mary Ann Leeper, FHC's senior strategic adviser.
The World Health Organization reviewed the scientific data and cleared the second-generation condom for purchase by UN agencies in 2006, FHC said. Since then, more than 23 million FC2 Female Condoms have been distributed in 77 countries.
Female Health shares jumped 53 cents, or 17.4 percent, to $3.58 in afternoon trading. The stock has traded between $1.76 and $4.60 during the past 52 weeks.